ArticleChina CDC weekly2025
Obesity Control and Cancer Prevention in China: Insights from the Weight Management Year.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity has emerged as a critical public health challenge worldwide and in China, substantially contributing to the burden of chronic diseases, including cancer. In response, China launched the "Weight Management Year" initiative in 2024, representing a strategic shift toward upstream interventions in chronic disease control. This perspective examines the essential role of obesity control in cancer prevention across the complete prevention continuum - primordial (zero-level), primary, secondary, and tertiary prevention. The initiative presents a unique opportunity to integrate weight management strategies into health promotion, early risk identification, screening programs, and post-diagnosis rehabilitation. It emphasizes incorporating obesity-related cancer prevention into routine healthcare through digital platforms, multidisciplinary collaboration, and population-wide education campaigns. However, significant challenges persist, including limited public awareness of obesity's carcinogenic risks, insufficient integration between clinical and public health systems, and inadequate multi-sectoral cooperation. Moving forward, cancer prevention in China must transition from a reactive, screening-focused model to a proactive, life-course approach centered on behavioral and lifestyle interventions. Strengthening risk communication, institutionalizing weight management across all prevention levels, and fostering cross-sectoral collaboration are essential for building a sustainable, population-wide cancer prevention framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.